AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33509192 — intervention group
Group type: EXPERIMENTAL
Intervention: ctDCS montages
Number of subjects: 10
Study 32694215 — intervention group
Group type: EXPERIMENTAL
Intervention: Albiglutide + optimized basal insulin glargine and lispro (dose reduced by 50% at randomization; lispro injections fully discontinued 4 weeks later)
Number of subjects: 814
Study 32694215 — intervention group
Group type: COMPARATOR
Intervention: Lispro + optimized glargine
Number of subjects: 814
Study 35196687 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional printed models
Number of subjects: 432
Study 35196687 — intervention group
Group type: COMPARATOR
Intervention: Two-dimensional pictures
Number of subjects: 432
Study 34764501 — intervention group
Group type: EXPERIMENTAL
Intervention: Isobaric levobupivacaine (0.5%, 0.3-0.4 mg/kg)
Number of subjects: 60
Study 34764501 — intervention group
Group type: COMPARATOR
Intervention: Isobaric ropivacaine (0.5%, 0.5 mg/kg)
Number of subjects: 60
Study 33459945 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial occlusion to the left arm
Number of subjects: 10
Study 33459945 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous stasis on the right arm
Number of subjects: 10
Study 34087126 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab plus pomalidomide and dexamethasone
Number of subjects: 304
Study 34087126 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide and dexamethasone
Number of subjects: 304
Study 32125249 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BET)
Number of subjects: 13
Study 32125249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 13
Study 34271979 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 50
Study 34271979 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity aerobic training
Number of subjects: 50
Study 33230706 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of whole rice straw (WRS), chopped rice straw (CRS), and zeolite (Z)
Number of subjects: 33
Study 33230706 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated wastewater
Number of subjects: 33
Study 35788657 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3676
Study 35936578 — intervention group
Group type: EXPERIMENTAL
Intervention: Telestroke model
Number of subjects: 22
Study 35936578 — intervention group
Group type: COMPARATOR
Intervention: Stroke physician model
Number of subjects: 22
Study 32115267 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography angiography (OCTA)
Number of subjects: 651
Study 32115267 — intervention group
Group type: COMPARATOR
Intervention: Fluorescein angiography (FA)
Number of subjects: 651
Study 32115267 — intervention group
Group type: EXPERIMENTAL
Intervention: OCTA
Number of subjects: 651
Study 32115267 — intervention group
Group type: COMPARATOR
Intervention: FA
Number of subjects: 651
Study 32546749 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage case with a 'no-water' sticker (test)
Number of subjects: 200
Study 32546749 — intervention group
Group type: COMPARATOR
Intervention: Storage case without a 'no-water' sticker (control)
Number of subjects: 200
Study 34221034 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosceles-configured SUN Teeth™ toothbrush
Number of subjects: 104
Study 34221034 — intervention group
Group type: COMPARATOR
Intervention: Standard reference toothbrush with end-rounded bristles
Number of subjects: 104
Study 32335531 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg body mass)
Number of subjects: 15
Study 32335531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 35400396 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload drink of 210 kcal
Number of subjects: 60
Study 32119790 — intervention group
Group type: EXPERIMENTAL
Intervention: Control-IQ using MyTDI parameters
Number of subjects: 20
Study 32119790 — intervention group
Group type: COMPARATOR
Intervention: Control-IQ using home settings
Number of subjects: 20
Study 32119790 — intervention group
Group type: EXPERIMENTAL
Intervention: Control-IQ (both groups)
Number of subjects: 20
Study 34106357 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivotal Response Treatment (PRT)
Number of subjects: 73
Study 34106357 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted Pivotal Response Treatment (PRT + robot)
Number of subjects: 73
Study 34106357 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 73
Study 33725842 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus short message service reminders (text message intervention)
Number of subjects: 100
Study 33725842 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study 33165631 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted TKA (RA-TKA)
Number of subjects: 60
Study 33165631 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA (C-TKA)
Number of subjects: 60
Study 33069784 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelial function guided treatment group
Number of subjects: 1000
Study 33069784 — intervention group
Group type: COMPARATOR
Intervention: Standard of care control group
Number of subjects: 1000
Study 34064968 — intervention group
Group type: EXPERIMENTAL
Intervention: Baked/boiled potatoes
Number of subjects: 30
Study 34064968 — intervention group
Group type: COMPARATOR
Intervention: Control (basal diet of 60 mmol/d)
Number of subjects: 30
Study 32097261 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior controllable antidisplacement and fusion (ACAF)
Number of subjects: 80
Study 32097261 — intervention group
Group type: COMPARATOR
Intervention: Laminoplasty
Number of subjects: 80
Study 32097261 — intervention group
Group type: EXPERIMENTAL
Intervention: ACAF
Number of subjects: 80
Study 33872825 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs) prescribed by PCPs
Number of subjects: 50
Study 33872825 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of DOACs among PCPs
Number of subjects: 50
Study 34191028 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily meal with 1 fresh Hass avocado
Number of subjects: 105
Study 34191028 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric meal without avocado (control)
Number of subjects: 105
Study 32871530 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity light therapy (LT-5000 lux)
Number of subjects: 142
Study 32871530 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity light therapy (LT-500 lux)
Number of subjects: 142
Study 32871530 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control (WLC)
Number of subjects: 142
Study 35879524 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 44
Study 32810344 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-sided games (SSG)
Number of subjects: 14
Study 34268638 — intervention group
Group type: EXPERIMENTAL
Intervention: Slowness therapy (weekly speech therapy sessions with stimuli played slowly on a PC)
Number of subjects: 23
Study 34268638 — intervention group
Group type: COMPARATOR
Intervention: Real-time stimuli speech therapy (age- and level-matched control group)
Number of subjects: 23
Study 34111616 — intervention group
Group type: COMPARATOR
Intervention: Xiao-Chai-Hu-Tang (XCHT)
Number of subjects: 0
Study 34111616 — intervention group
Group type: COMPARATOR
Intervention: Manipulation of gut bacteria (via FMT or antibiotics)
Number of subjects: 0
Study 32125522 — intervention group
Group type: EXPERIMENTAL
Intervention: Music during labor
Number of subjects: 30
Study 32125522 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 30
Study 36102337 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa extract (500 mg/day flavanols)
Number of subjects: 2262
Study 36102337 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin-mineral (MVM) supplementation
Number of subjects: 2262
Study 33159574 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (menaquinone-7) 180 µg twice a day for 12 weeks
Number of subjects: 68
Study 33159574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 32464082 — intervention group
Group type: EXPERIMENTAL
Intervention: FS4 strategy
Number of subjects: 12
Study 32464082 — intervention group
Group type: COMPARATOR
Intervention: FSP strategy
Number of subjects: 12
Study 33545136 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided biliary drainage (EUS-BD) using lumen-apposing metal stents
Number of subjects: 20
Study 33545136 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided biliary drainage (EUS-BD)
Number of subjects: 20
Study 33228575 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (15 mg orally)
Number of subjects: 63
Study 33228575 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (15 mg orally) with abnormally low prolactin levels
Number of subjects: 63
Study 33228575 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (15 mg orally) without abnormally low prolactin levels
Number of subjects: 63
Study 35266064 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time operation video (Group A)
Number of subjects: 124
Study 35266064 — intervention group
Group type: EXPERIMENTAL
Intervention: Explanation about the operation process (Group B)
Number of subjects: 124
Study 35266064 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time operation video + Explanation about the operation process (Group C)
Number of subjects: 124
Study 35266064 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Group D)
Number of subjects: 124
Study 32302504 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 (5 μg/day for 100 days)
Number of subjects: 200
Study 32302504 — intervention group
Group type: COMPARATOR
Intervention: Standard supplementation (350 mg/day ferrous iron, 5 mg folic acid)
Number of subjects: 200
Study 32302504 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 200
Study 35624509 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led inhaler technique assessment service
Number of subjects: 39
Study 35624509 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 39
Study 33064182 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg once daily)
Number of subjects: 120
Study 33064182 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval-based exercise (5 days/week, 30 min/session)
Number of subjects: 120
Study 33064182 — intervention group
Group type: COMPARATOR
Intervention: Metformin (1700 mg daily)
Number of subjects: 120
Study 33064182 — intervention group
Group type: COMPARATOR
Intervention: Control (habitual lifestyle)
Number of subjects: 120
Study 33189805 — intervention group
Group type: EXPERIMENTAL
Intervention: No advanced airway
Number of subjects: 2058
Study 33189805 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraglottic airway (SGA)
Number of subjects: 2058
Study 33189805 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal intubation
Number of subjects: 2058
Study 33189805 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of airway strategies
Number of subjects: 2058
Study 33189805 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2058
Study 33189370 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D - 30 mL of 0.5% levobupivacaine with vasoconstrictor and 6 mg (1.5 mL) of dexamethasone
Number of subjects: 74
Study 33189370 — intervention group
Group type: COMPARATOR
Intervention: Group C - 30 mL of 0.5% levobupivacaine with vasoconstrictor and 1.5 mL of 0.9% saline
Number of subjects: 74
Study 33189370 — intervention group
Group type: COMPARATOR
Intervention: Group C
Number of subjects: 74
Study 33189370 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D
Number of subjects: 74
Study 33189370 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 74
Study 35787963 — intervention group
Group type: COMPARATOR
Intervention: CRASH model
Number of subjects: 423
Study 33172907 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidable significant harm incidents
Number of subjects: 14407
Study 33172907 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic errors
Number of subjects: 14407
Study 33172907 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication-related problems
Number of subjects: 14407
Study 33172907 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed referrals
Number of subjects: 14407
Study 33172907 — intervention group
Group type: EXPERIMENTAL
Intervention: Actions aligned with evidence-based guidelines
Number of subjects: 14407
Study 32674208 — intervention group
Group type: EXPERIMENTAL
Intervention: Relugolix (Relumina)
Number of subjects: 0
Study 32674208 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide (Lupron)
Number of subjects: 0
Study 34935191 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 149
Study 34935191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 33218692 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Group (NG)
Number of subjects: 104
Study 33218692 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Group (UG)
Number of subjects: 104
Study 34656987 — intervention group
Group type: EXPERIMENTAL
Intervention: SB11
Number of subjects: 705
Study 33352474 — intervention group
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 241
Study 33352474 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and pubertal development influence on cortisol response
Number of subjects: 241
Study 33352474 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis by TSST timepoint interaction
Number of subjects: 241
Study 35944003 — intervention group
Group type: EXPERIMENTAL
Intervention: ActTeens physical activity program
Number of subjects: 140
Study 34628743 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion combined with Daiwenjiu plaster
Number of subjects: 240
Study 34628743 — intervention group
Group type: COMPARATOR
Intervention: Conventional observation (Control)
Number of subjects: 240
Study 34286398 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealing with resin-modified glass-ionomer cement (RMGIC)
Number of subjects: 68
Study 34286398 — intervention group
Group type: COMPARATOR
Intervention: Restoration with resin-modified glass-ionomer cement (RMGIC)
Number of subjects: 68
Study 33727522 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.075 mg/kg oxycodone (Group A)
Number of subjects: 119
Study 33727522 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg oxycodone (Group B)
Number of subjects: 119
Study 33727522 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg oxycodone (Group C)
Number of subjects: 119
Study 33727522 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and 0.075 mg/kg oxycodone (Group A)
Number of subjects: 119
Study 33727522 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and 0.1 mg/kg oxycodone (Group B)
Number of subjects: 119
Study 33727522 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and 0.125 mg/kg oxycodone (Group C)
Number of subjects: 119
Study 35636580 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic vibratory stimulation (SVS) during device on (N)
Number of subjects: 30
Study 35636580 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (Phase 1)
Number of subjects: 30
Study 32064596 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical rapamycin 0.1%
Number of subjects: 52
Study 32064596 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical calcitriol 0.0003%
Number of subjects: 52
Study 32064596 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical rapamycin-calcitriol combination
Number of subjects: 52
Study 35226053 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE)
Number of subjects: 250
Study 35226053 — intervention group
Group type: COMPARATOR
Intervention: Supportive psychotherapy (control)
Number of subjects: 250
Study 32271151 — intervention group
Group type: EXPERIMENTAL
Intervention: Social group-based strategy including tutorial on exercise monitoring, encouragement to share exercise records, and assistance with activity tracker use.
Number of subjects: 149
Study 32271151 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving wrist-worn activity trackers and instructions without additional intervention.
Number of subjects: 149
Study 35294537 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg orally twice daily for 10 days
Number of subjects: 205
Study 35294537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 33077124 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise passive-heating condition (suit worn for 1 hour after 1-hour walking)
Number of subjects: 19
Study 33077124 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive-heating condition (suit worn for 2 hours)
Number of subjects: 19
Study 33077124 — intervention group
Group type: COMPARATOR
Intervention: Exercise-only condition (1-hour treadmill walking followed by 1-hour rest)
Number of subjects: 19
Study 34298398 — intervention group
Group type: EXPERIMENTAL
Intervention: ω-3 polyunsaturated fatty acid treatment
Number of subjects: 126
Study 34298398 — intervention group
Group type: EXPERIMENTAL
Intervention: General treatment
Number of subjects: 126
Study 34298398 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 126
Study 32502876 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (1.8 mg/kg once every 3 weeks; ≤16 cycles)
Number of subjects: 0
Study 32502876 — intervention group
Group type: COMPARATOR
Intervention: Physician's choice (methotrexate/bexarotene; ≤48 weeks)
Number of subjects: 0
Study 32502876 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin
Number of subjects: 0
Study 32502876 — intervention group
Group type: COMPARATOR
Intervention: Physician's choice
Number of subjects: 0
Study 32502876 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (in patients with peripheral neuropathy)
Number of subjects: 0
Study 32502876 — intervention group
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (in patients without peripheral neuropathy)
Number of subjects: 0
Study 37150125 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsules (Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI)
Number of subjects: 63
Study 37150125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 37150125 — intervention group
Group type: EXPERIMENTAL
Intervention: Indole-3-propionic acid (IPA) (5 μM) in vitro
Number of subjects: 63
Study 33068425 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine once-weekly (400 mg)
Number of subjects: 1483
Study 33068425 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine twice-weekly (400 mg)
Number of subjects: 1483
Study 33068425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1483
Study 32143727 — intervention group
Group type: COMPARATOR
Intervention: Gyejibongnyeong-Hwan
Number of subjects: 0
Study 36075892 — intervention group
Group type: EXPERIMENTAL
Intervention: PRS‐PGx‐Bayes
Number of subjects: 0
Study 36075892 — intervention group
Group type: EXPERIMENTAL
Intervention: Other PRS‐PGx methods
Number of subjects: 0
Study 36075892 — intervention group
Group type: COMPARATOR
Intervention: Disease PRS methods
Number of subjects: 0
Study 33814437 — intervention group
Group type: EXPERIMENTAL
Intervention: β-lactolin
Number of subjects: 30
Study 33814437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34275797 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib ± cisplatin ± pemetrexed
Number of subjects: 115
Study 34275797 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin ± pemetrexed
Number of subjects: 115
Study 35947252 — intervention group
Group type: EXPERIMENTAL
Intervention: First batch of mydriasis
Number of subjects: 30
Study 35947252 — intervention group
Group type: EXPERIMENTAL
Intervention: Second batch of mydriasis (5 hours later)
Number of subjects: 30
Study 32453167 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA) ventilation
Number of subjects: 77
Study 32453167 — intervention group
Group type: COMPARATOR
Intervention: Rigid bronchoscope ventilation
Number of subjects: 77
Study 32453167 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA ventilation
Number of subjects: 77
Study 35897037 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (5 billion colony-forming units/day for 6 weeks)
Number of subjects: 32
Study 35897037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 36069596 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron repletion (one-gram low molecular weight iron dextran)
Number of subjects: 79
Study 36069596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 36069596 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron repletion
Number of subjects: 79
Study 33629326 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 12
Study 33629326 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (placebo or nothing)
Number of subjects: 12
Study 32525564 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) during cisplatin-based chemotherapy (CBCT) for testicular cancer (TC). The intervention included two weekly HIIT sessions, each with 2 to 4 intervals of 2 to 4 minutes at 85% to 95% of peak heart rate for 9 to 12 weeks.
Number of subjects: 19
Study 32525564 — intervention group
Group type: COMPARATOR
Intervention: Single lifestyle counseling session (control group).
Number of subjects: 19
Study 34978859 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive AF screening with an implantable loop recorder
Number of subjects: 0
Study 34978859 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34296794 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolved isolates of B. subtilis
Number of subjects: 0
Study 34296794 — intervention group
Group type: EXPERIMENTAL
Intervention: Mix of evolved isolates
Number of subjects: 0
Study 35031139 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted sampling (TS)
Number of subjects: 38